Abstract:BACKGROUND: Antimicrobial resistance (AMR) has posed a serious threat to global public health and it requires immediate action, preferably long term. Current drug therapies have failed to curb this menace due to the ability of microbes to circumvent the mechanisms through which the drugs act. From the drug discovery point of view, the majority of drugs currently employed for antimicrobial therapy are small molecules. Recent trends reveal a surge in the use of peptides as drug candidates as they offer remarkable advantages over small molecules.METHODS: Newer synthetic strategies like organometalic complexes, Peptide-polymer conjugates, solid phase, liquid phase and recombinant DNA technology encouraging the use of peptides as therapeutic agents with a host of chemical functions, and tailored for specific applications. In the last decade, many peptide based drugs have been successfully approved by the Food and Drug Administration (FDA). This success can be attributed to their high specificity, selectivity and efficacy, high penetrability into the tissues, less immunogenicity and less tissue accumulation. Considering the enormity of AMR, the use of Antimicrobial Peptides (AMPs) can be a viable alternative to current therapeutics strategies. AMPs are naturally abundant allowing synthetic chemists to develop semi-synthetics peptide molecules. AMPs have a broad spectrum of activity towards microbes and they possess the ability to bypass the resistance induction mechanisms of microbes.RESULT: The present review focuses on the potential applications of AMPs against various microbial disorders and their future prospects. Several resistance mechanisms and their strategies have also been discussed to highlight the importance in the current scenario.CONCLUSION: Breakthroughs in AMP designing, peptide synthesis and biotechnology have shown promise in tackling this challenge and has revived the interest of using AMPs as an important weapon in fighting AMR.

Antimicrobial peptides, conventional antibiotics, and their synergistic utility for the treatment of drug‐resistant infections

Antimicrobial Peptide Synergies for Fighting Infectious Diseases

Antimicrobial peptides as promising antibiotic adjuvants to combat drug-resistant pathogens

Synergistic action of antimicrobial peptides and antibiotics: current understanding and future directions

Antimicrobial peptides for combating drug-resistant bacterial infections

Combating bacterial resistance by combination of antibiotics with antimicrobial peptides

Mechanisms of Action, Biological Characteristics, and Future Prospects: A Review of Antimicrobial Peptides (A Review)

AMP-Mimetic Antimicrobial Polymer-Involved Synergic Therapy with Various Coagents for Improved Efficiency

Antimicrobial peptides: mechanism of action, activity and clinical potential

Antimicrobial Peptides and Their Biomedical Applications: A Review

Combating Antimicrobial Resistance by Employing Antimicrobial Peptides: Immunomodulators and Therapeutic Agents against Infectious Diseases

Antimicrobial Peptides: A Promising Solution to the Rising Threat of Antibiotic Resistance

Antimicrobial peptide-based strategies to overcome antimicrobial resistance

Antimicrobial Peptides: From Design to Clinical Application

Complementary Activities of Host Defence Peptides and Antibiotics in Combating Antimicrobial Resistant Bacteria

Antimicrobial Peptides as Effective Agents Against Drug-Resistant Pathogens

Chemical modifications to increase the therapeutic potential of antimicrobial peptides

Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance

Chemically modified and conjugated antimicrobial peptides against superbugs.

Antimicrobial Peptides: Diversity, Mechanism of Action and Strategies to Improve the Activity and Biocompatibility In Vivo

Biochemistry, Mechanistic Intricacies, and Therapeutic Potential of Antimicrobial Peptides: An Alternative to Traditional Antibiotics